Necroptosis contributes to airborne particulate matter-induced ocular surface injury

Kexin Shi1, Qichuan Yin1, Xiajing Tang1

  • 1The Eye Center, Second Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China; Zhejiang Provincial Key Lab of Ophthalmology, Hangzhou, Zhejiang Province, China.

Toxicology
|March 5, 2022
PubMed

Insights

Airborne particulate matter (PM) causes ocular surface injury by triggering necroptosis, a programmed cell death. The necroptosis inhibitor Necrostatin-1 (Nec-1) effectively reduced PM-induced eye damage and inflammation.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Environmental Health

Background:

  • Airborne particulate matter (PM) poses a significant threat to ocular surface health.
  • The precise mechanisms underlying PM-induced ocular surface injury are not fully understood.
  • Necroptosis, a regulated form of necrosis, is increasingly recognized in various disease pathologies.

Purpose of the Study:

  • To investigate the role of necroptosis in the pathogenesis of ocular surface injury induced by airborne particulate matter (PM).
  • To evaluate the therapeutic potential of necroptosis inhibition in mitigating PM-induced ocular surface damage.

Main Methods:

  • Human corneal epithelial (HCE) cells and a mouse ocular surface model were exposed to PM.
  • Necroptosis-related protein expression, cell viability, reactive oxygen species (ROS) levels, and mitochondrial membrane potential were assessed.
  • Inflammatory cytokine and mucin expression were quantified using ELISA, immunofluorescence, and qRT-PCR.
  • The effects of Necrostatin-1 (Nec-1), a necroptosis inhibitor, were evaluated both in vitro and in vivo.

Main Results:

  • PM exposure induced HCE cell damage, characterized by decreased viability, increased ROS, and loss of mitochondrial membrane potential, via necroptosis.
  • Nec-1 significantly attenuated PM-induced HCE cell damage and reduced inflammatory cytokine production.
  • Nec-1 inhibited PM-induced decrease in mucin expression in HCE cells.
  • In vivo, Nec-1 treatment reduced corneal inflammation and mucin underproduction in the mouse ocular surface following PM exposure.

Conclusions:

  • Necroptosis plays a critical role in the pathogenesis of PM-induced ocular surface injury.
  • Nec-1 demonstrates significant therapeutic potential in ameliorating PM-related ocular surface inflammation and dysfunction.
  • Targeting necroptosis with inhibitors like Nec-1 offers a promising strategy for treating ocular surface disorders, including dry eye disease exacerbated by air pollution.